about
Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data BaseCHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience.TNFRSF10C copy number variation is associated with metastatic colorectal cancer.The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma.Cholangiocarcinoma size on magnetic resonance imaging versus pathologic specimen: Implications for radiation treatment planning.Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC.Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.Palliative care and palliative radiation therapy education in radiation oncology: A survey of US radiation oncology program directors.High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma.Outcomes of ICU Admission of Patients With Progressive Metastatic Gastrointestinal Cancer.Palliative Care Specialist Series: Top 10 Tips Palliative Care Clinicians Should Know About Radiation Oncology.Author's Response.Discharge to Subacute Rehabilitation Facilities Does Not Benefit Patients Hospitalized With Progressive Gastrointestinal Cancer.Dose escalation for locally advanced pancreatic cancer: How high can we go?Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostateKinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical CancerBrachytherapy Training Survey of Radiation Oncology ResidentsTop Concerns of Radiation Oncology Trainees in 2019: Job Market, Board Examinations, and Residency ExpansionSelective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerA Survey Study of Female Radiation Oncology Residents' Experiences to Inform ChangeMicrobial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical CancerEvaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the AbdomenMicrobiome factors in HPV-driven carcinogenesis and cancers
P50
Q30726275-C452455C-BDE9-4E5C-8DE7-3D0C0FAF25B8Q33630872-5E16C6FB-8A54-48A8-9B32-6A363D0396DEQ35320095-DCFCC012-0824-4D36-A215-668E1CCF8C48Q35419356-3460BAEB-E9BF-4F00-B3C3-A5A732E4D40DQ36936939-1BA1DF1D-B0F3-47CF-AF1F-C17A722C262AQ37723257-FB5E540E-DD83-4192-A763-08EFD1076B15Q38775746-0C119748-9686-4C21-9EF7-7DFFFAD3690BQ43379696-3159C47A-FC3E-4665-853C-8DDE63056E5CQ43989091-7F9BB9D4-757B-4B93-90C5-3648CAE09522Q46058036-3BB5A97F-4721-4C5F-B3B4-9BC7BE415014Q47163638-F091C2DD-2AEC-4BFE-B9F9-A976AC13F836Q47274842-E95B093C-E1DD-410E-9EFB-98B608B61EA6Q50066895-424FB636-2FC5-440E-86F1-17908547F75BQ52780640-8DE499F5-BEE3-4D64-B085-CD1B2D98AEDFQ53336269-C851271E-6CBD-4854-88DA-70EB51EE37C2Q58119172-7DFAC4C2-26F6-40D0-B869-FDD9FB37F9FEQ87535023-A431BC76-FB4A-443A-A9C9-A340F588C97DQ90290276-215CE375-87B1-4C97-AF0A-43D5FEF28816Q90909162-76E237D6-DB9A-4D0C-9188-0019D915BFF3Q90927656-949E47A4-62BD-4B89-9094-8C9807AE07F3Q91674309-A0036765-25FB-4856-BBAA-35931506EBFFQ92158712-965B29D2-9F5B-41E4-9561-389A6AD52873Q92975866-6FC843B2-D1C9-4D9B-907A-A6829E0C4D76Q92976276-2346BB15-96E2-498A-A902-6860BCA5C1C6Q96121659-24E0FB86-01F5-453F-AFFF-C67128CC8E11
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
L E Colbert
@en
L E Colbert
@nl
type
label
L E Colbert
@en
L E Colbert
@nl
prefLabel
L E Colbert
@en
L E Colbert
@nl
P31
P496
0000-0001-5806-4339